EyePoint Pharmaceuticals
EYPT
#6474
Rank
S$0.76 B
Marketcap
$11.24
Share price
-6.76%
Change (1 day)
37.34%
Change (1 year)

Operating Margin for EyePoint Pharmaceuticals (EYPT)

Operating Margin as of November 2024 (TTM): -153.66%

According to EyePoint Pharmaceuticals 's latest financial reports and stock price the company's current Operating Margin is -153.66%. At the end of 2023 the company had an Operating Margin of -153.66%.

Operating Margin history for EyePoint Pharmaceuticals from 2002 to 2024

Operating Margin at the end of each year

Year Operating Margin Change
2023-153.66%-37.78%
2022-246.97%56.17%
2021-158.14%19.97%
2020-131.82%-52.73%
2019-278.88%-84.47%
2018-1,795.71%632.37%
2017-245.19%-81.7%
2016-1,339.63%-5623.4%
201524.25%-106.25%
2014-388.28%-30.76%
2013-560.76%-20.92%
2012-709.13%298.02%
2011-178.17%-568.01%
201038.07%-233.74%
2009-28.47%-98.7%
2008-2,190.82%-61.51%
2007-5,691.41%197.97%
2006-1,910.03%-24.56%
2005-2,531.90%28.52%
2004-1,969.97%-59.3%
2003-4,839.72%1009.85%
2002-436.07%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
26.89%-117.50%๐Ÿ‡บ๐Ÿ‡ธ USA
-234,760.00% 152,678.86% Bahamas

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.